Company: HCTI
Filing Date: 2025-02-18
Form Type: 10-K/A
Source: 0001213900-25-014503
Chunk: 77

Company: Healthcare Triangle, Inc.
Filing Date: 2025-02-18
Form: 10-K/A
Chunk 77
---
           |      - |   |     | $                 |  1,341 |   |
| Cash and cash equivalents at the end of the period                |     | $                              |   1,234 |   |     | $           |      - |   |     | $                 |  1,234 |   |
| Supplementary disclosure of cash flows information                |     |                                |         |   |     |             |        |   |     |                   |        |   |
| Interest                                                          |     | $                              |     968 |   |     | $           |      - |   |     | $                 |    968 |   |
| Income taxes                                                      |     | $                              |      35 |   |     | $           |      - |   |     | $                 |     35 |   |
| Non-cash flows information:                                       |     |                                |         |   |     |             |        |   |     |                   |        |   |
| Contingent consideration settled with common stock (x)            |     | $                              |       - |   |     | $           |    125 |   |     | $                 |    125 |   |
| Relative fair value of warrants issued with convertible debt (xi) |     | $                              |       - |   |     | $           |    356 |   |     | $                 |    356 |   |

Notes:

| (i) | Write back of amortization                                      
 due to intangible write-off and reclassification of impairment. |

| (ii) | Reclassification                                                  
 and impairment of intangible relating to Devcool Inc acquisition. |

| (iii) | Adjustment $12 related to reclassification from accounts payable and accrued expenses |

| (iv) | Adjustment related to fair value of shares issued for Professional fees of $56 |

| (v) | Adjustment related to ESOP cost true-up $149 |

| (vi) | Adjustment related                                                                        
 to Seacoast collection account in January 2024, reported earlier as collected adjusted to 
 accounts receivable. Corresponding impact given in short term borrowing.                  |

| (vii) | The Company recorded $435 as debt issuance cost for the period ending December 31, 2023. |

| (viii) | Adjustments                                             
 related to accrued professional fees and tax liability. |

| (ix) | Sale of fixed 
 assets.       |

| (x